Trademark Search  /  REYON

REYON

○ Dead · Abandoned

U.S. federal trademark · Serial No. 88160759

Mark
REYON
Status
Abandoned
Serial Number
88160759
Filing Date
October 18, 2018
Class(es)
Class 005

Owners

Reyon Pharmaceutical Co., Ltd
03 · Seoul, KR
Reyon Pharmaceutical Co., Ltd
03 · Seoul, KR

Goods & Services

Anaesthetics; Anti-cancer preparations; Anti-inflammatory and antipyretic preparations; Antibiotics; Antihistamines; Antivirals; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Diagnostic preparations for medical purposes; Diagnostic reagents and contrast media for medical use; Hormonal preparations; Hormones for medical purposes; Ocular pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for use in urology; Pharmaceutical products for treating respiratory diseases; Psychotropics; Therapeutic vaccines; Tumor suppressing agents; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "REYON" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.